PeptidePedia The community reference

Talk:Aspiration risk under anaesthesia

Discussion page·2 threads·no archives

This article is within the scope of the clinical practice working group.

This is the discussion page for the article Aspiration risk under anaesthesia. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Caution proportionate to severity, not evidenceResolved

Saying that guidance is cautious in proportion to the severity of the outcome rather than the strength of the evidence is exactly right and is rarely said out loud. — AnaesthesiaAoife (talk) 09:40, 1 April 2026 (UTC)

It also defends the guidance rather than undermining it — that is a reasonable way to handle a rare severe risk. ✓ Done — HedgeHedda (talk) 13:15, 1 April 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Ultrasound measures the thing itselfDone

Direct assessment beats any rule derived from the drug, and the article makes that the central practical point. — ClinicCorrespondent (talk) 10:25, 15 June 2026 (UTC)

Which is also why the later guidance moved towards individualised assessment. ✓ Done — AnaesthesiaAoife (talk) 14:00, 15 June 2026 (UTC)

Done. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.
This page was last edited on 15 June 2026, by AnaesthesiaAoife. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).